Anthony G. Quinn - President & CEO, Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
SYRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Anthony G. Quinn since 10/5/2023

Holdings reported by Anthony G. Quinn for Spyre Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 551K $391K $0.71 Mar 16, 2022 Direct
Common Stock 266K $189K $0.71 Mar 16, 2022 By trusts

Transactions reported by Anthony G. Quinn for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.